Aldeyra Therapeutics, Inc.ALDXNASDAQ
Loading
PB Ratio: Discounted ValuationCompressed
Percentile Rank21
3Y CAGR-98.6%
5Y CAGR-92.9%
Studio
Year-over-Year Change

Price-to-book ratio

3Y CAGR
-98.6%/yr
vs +6.7%/yr prior
5Y CAGR
-92.9%/yr
Recent deceleration
Acceleration
-105.3pp
Decelerating
Percentile
P21
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 yr
Consecutive declineCompressed
PeriodValueYoY Change
20250.00-100.0%
20244.18+142.1%
20231.73-35.8%
20222.69+156.2%
20211.05-73.2%
20203.92+19.5%
20193.28+57.7%
20182.08-24.0%
20172.73-2.5%
20162.81-